A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Clinical trial NCT01047319 · TERMINATED
Trial details
- NCT number
- NCT01047319
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-27
- Primary completion
- 2017-06-30
- Enrollment
- 1047
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.